Healthcare specialist SHS Capital invests in a leading German Endoscopy Group

 

 

 

 

SHS Capital invests through its SHS VI fund in a consortium of four German medical technology companies focused on endoscopy systems, comprising EMOS Technology, InnoView, ILO electronic and Micon. 

The Endoscopy Group develops and manufactures high-quality, reusable flexible, rigid and semi-flexible endoscopes as well as camera and light systems and insufflators. The products are used in a wide range of minimally invasive procedures and diagnostics, including ENT, urology, gynaecology, orthopaedics, laparoscopy, bronchoscopy and veterinary medicine. All essential steps in the value chain, from optics manufacturing through to final assembly, are carried out at modern facilities in Germany. The group is positioned primarily as a supplier to national and international OEM customers and distributors.     

Under the leadership of founder and managing director Frank Spillner, the group was established as the endoscopy arm of G. Heinemann Medizintechnik GmbH. Through the acquisition of the endoscopy and imaging specialists ILO electronic, Micon Medizintechnik, EMOS Technology and InnoView, a platform with a broad product portfolio has been created. With the entry of SHS, the group is now set to grow even closer together and further strengthen its position as an integrated platform.

SHS intends to accompany the Endoscopy Group as a growth partner in the coming years and support its development through growth initiatives focused on expanding relationships with existing customers, further internationalisation and the development of additional products.

“With SHS, we have found a long-term-oriented partner with proven MedTech expertise who understands our business model and shares our vision of an integrated endoscopy platform,” explains Frank Spillner. “The investment enables us to invest in innovation, manufacturing and international market development while at the same time implementing a structured succession solution for the endoscopy business that actively preserves our DNA as a reliable, quality-leading ‘Made in Germany’ manufacturer.”

“The Endoscopy Group is one of the few European manufacturers covering the entire spectrum of endoscopes, imaging and accessories with a high degree of in-house manufacturing, positioning itself as a strategic partner for OEMs and distributors worldwide,” says Tobias Fuchs, Senior Investment Manager at SHS Capital. “On this basis, we aim develop a leading European endoscopy platform together with the ambitious management team and further scale the international business.”

About the Endoscopy Group
The Endoscopy Group consists of EMOS Technology GmbH, InnoView GmbH, ILO electronic GmbH and Micon Medizintechnik GmbH. The group develops and manufactures high-quality, reusable flexible, rigid and semi-flexible endoscopes as well as camera and light systems and insufflators for a broad range of minimally invasive procedures, including ENT, urology, gynaecology, orthopaedics, laparoscopy, bronchoscopy and veterinary medicine. All key value creation steps take place at modern sites in Germany. The group primarily supplies international OEM customers and distributors and is distinguished by strong technical expertise, continuous product innovation and very high customer loyalty. The group’s customers are located in Europe, North America, Latin America and Asia.

About SHS Capital
SHS Capital is a private equity provider founded in 1993 that invests in healthcare companies in Europe. The focus of the investments is on expansion financing, shareholder changes and succession situations. "Building European Healthcare Champions" is the investment philosophy according to which SHS finances and develops portfolio companies. The Tübingen-based investor takes both minority and majority stakes. The national and international investors in SHS funds include pension funds, funds of funds, foundations, family offices, strategic investors, entrepreneurs and the SHS management team. The equity or equity-like investment of the AIF is up to € 50 million. Volumes in excess of this can be realised with a network of co-investors. In its investment decisions, SHS attaches great importance to the consideration of ESG aspects and has therefore committed itself to the guidelines of the UN PRI. SHS is currently investing from its sixth fund, which was launched in 2022 and has a volume of ca. € 270 million.

More information at: www.shs-capital.eu

Are you interested in receiving regular updates about SHS? Subscribe to our Newsletter and follow us on LinkedIn.

PR contact:
Regine Hujer
SHS Gesellschaft für Beteiligungsmanagement mbH
Bismarckstrasse 12
72072 Tuebingen
tuebingen@shs-capital.eu